Année : 2026
-
Cadence Unveils Industry’s First Fully Autonomous Virtual Engineer for Chip Design, powered by NVIDIA
Level-5 ChipStack AI Super Agent framework and NVIDIA OpenShell runtime advance secure, agentic AI across semiconductor developmentSAN JOSE, Calif.--(BUSINESS WIRE)--At…
Lire la suite » -
HPE Introduces CPU Server with NVIDIA Vera CPU, Purpose-built for Agentic AI
New HPE ProLiant Compute DL394 Gen12 combines the capabilities of NVIDIA Vera CPUs with industry-leading security and management to accelerate…
Lire la suite » -
Invisix Raises €20M Seed Round to Bring Soft X-Ray Metrology to AI-Era Chip Manufacturing
As semiconductor devices become increasingly complex, optical measurement tools can no longer see inside, creating a critical manufacturing bottleneck Invisix…
Lire la suite » -
Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its potential to deliver best-in-class weight loss across a…
Lire la suite » -
Nidec Announces Glass Lewis’s Report Recommending Votes in Favor of All Company Proposals at Nidec’s 53rd Regular General Meeting of Shareholders
KYOTO, Japan--(BUSINESS WIRE)--Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company” or “we”) hereby announces that Glass Lewis & Co.,…
Lire la suite » -
Morse Micro Announces MM8108-M20 High-Power Wi-Fi HaLow Module to Accelerate Long-Range IoT Adoption
New module gives OEMs, ODMs and partners a faster path to commercial Wi-Fi HaLow products across industrial, smart building and…
Lire la suite » -
Power Integrations Unveils Space-Saving, Ultra-Slim Auxiliary PSU Reference Designs for NVIDIA Kyber 800 VDC AI Data Center
Compact, low-profile designs use highly integrated, 1700 V-rated PowiGaN™, single-HEMT ICs to save space, simplify designs, improve reliability and lower…
Lire la suite » -
FPT and UOB Sign MoU to Advance AI, Technology Transformation and Financial Innovation
SINGAPORE--(BUSINESS WIRE)--$FPT #AI--Global technology corporation FPT and UOB have signed a Memorandum of Understanding (MoU) to explore strategic collaboration opportunities…
Lire la suite » -
Ventiva Partners with ASUS to Explore Next-Generation Thermal Architectures for Compact AI Computing Systems
TAIPEI, Taiwan--(BUSINESS WIRE)--Ventiva®, a leader in solid-state cooling solutions, today announced at Computex 2026 a strategic partnership with ASUS to…
Lire la suite » -
Mobvista (1860.HK) Delivers Solid 2026 Q1 Performance Fueled by AI-Driven Advertising
SINGAPORE--(BUSINESS WIRE)--Mobvista (1860.HK), a leading technology platform providing global growth solutions, today announced its financial results for the quarter ended…
Lire la suite » -
Best’s Market Segment Report: Japan Life Insurers’ Use of Reinsurance More Than Doubled Since 2020
HONG KONG--(BUSINESS WIRE)--#insurance--Japan’s life insurers have increasingly relied on reinsurance in recent years, with the overall cession rate as a…
Lire la suite » -
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Total Sales and Shipments of EAI Robots Reached 69 Units in May, a New Record, Exceeding the Combined Total for the Months of March and April
FF has formally submitted a referral letter to the SEC regarding potentially illegal short selling and market manipulation, as we…
Lire la suite » -
VRRM Investors Have Opportunity to Join Verra Mobility Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--$VRRM--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Lire la suite » -
PLAB Investors Have Opportunity to Join Photronics, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--$PLAB--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Lire la suite » -
CZR Investors Have the Opportunity to Join Investigation of Caesars Entertainment, Inc. with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--$CZR--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Lire la suite » -
Berkshire Hathaway to Acquire Taylor Morrison Home Corporation for $8.5 Billion
All-cash transaction delivers significant and certain value for Taylor Morrison shareholders; purchase price represents approximately 24% premium to latest closing…
Lire la suite » -
GAP Investors Have Opportunity to Join The Gap, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--$GAP--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Lire la suite » -
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China
Ivonescimab Plus Chemotherapy Reduced the Risk of Death by 34% Compared to Tislelizumab Plus Chemotherapy; Hazard Ratio 0.66 First Regimen…
Lire la suite » -
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced…
Lire la suite » -
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
Cohort 3 analysis from the Phase 3 BREAKWATER study showed a 56% reduction in the risk of disease progression or…
Lire la suite » -
Kelonia Therapeutics Presents Updated First-in-Human Data from Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
100% ORR and MRD-negative responses observed in all evaluable patients, earliest dosed patients remain in ongoing MRD negative response beyond…
Lire la suite » -
ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
Phase II ARACOG (AFT-47) head-to-head trial met its primary endpoint, with patients treated with NUBEQA® (darolutamide) showing a decline in…
Lire la suite » -
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
Robust enrollment of 173 patients across dose escalation and expansion cohorts, with objective responses observed across five tumor types JK06…
Lire la suite » -
BW LPG Enters Into Agreement for Eight 90’cbm Panamax Newbuildings with Hyundai Heavy Industries
SINGAPORE--(BUSINESS WIRE)--BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG.OL”), the world’s leading owner and operator of LPG…
Lire la suite » -
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
- Late-breaking VISTAS results demonstrate rapid, sustained, and clinically meaningful reductions in pruritus with volixibat in primary sclerosing cholangitis (PSC)…
Lire la suite » -
CVLT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Commvault Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--$CVLT #CVLT--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Commvault…
Lire la suite » -
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sportradar Group AG (SRAD) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--$SRAD #SRAD--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sportradar…
Lire la suite » -
Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026
Sentinel Agents™, NexusPulse™ Intelligent Calculators, DrArturo AI™, Phoebe AI™, Patient Connect™, and TrialRelay™ create a real-time multi-agent orchestration layer for…
Lire la suite » -
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
– CABOMETYX significantly reduced the risk of disease progression or death by 74% and 60% in patients with non-functional and…
Lire la suite » -
Global Real Assets Trust Reports Q1 2026 Results
TORONTO--(BUSINESS WIRE)--Starlight Investments Capital GP Inc. ("Starlight Capital"), on behalf of Global Real Assets Trust (the "Trust"), announced today the…
Lire la suite »